Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-04-27

Clinical Trial Update: Subclinical Organ Damage in Overweight and Obese Patients: Does Presence of Metabolic Syndrome Matter?

View source ↗

Summary

The article reports a clinical trial evaluating whether metabolic syndrome affects subclinical organ damage in overweight and obese individuals. The trial statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Goztepe Training and Research Hospital | Conditions: Metabolic Syndrome, Subclinical Organ Damage | Status: UNKNOWN